[Comment] Marketing of supplements to people with ADHD reinforces stigma | ClinicLens
The global prevalence of ADHD is around 2–5% in adults, with stimulant medications remaining the cornerstone of treatment.1 Randomised controlled trials and meta-analyses have shown that stimulant medications, such as methylphenidate and amphetamine formulations, improve attentio
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.